Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673220 | 1.00 | TSHR (0.58) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL672840 | 1.00 | TSHR (0.58) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL672392 | 0.98 | TSHR (0.60) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL10426942 | 0.91 | TSHR (0.59) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL10427255 | 0.91 | TSHR (0.59) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL10427197 | 0.91 | TSHR (0.65) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL21385195 | 0.90 | TSHR (0.53) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL11647433 | 0.90 | TSHR (0.63) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL29940620 | 0.90 | TSHR (0.63) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL10150608 | 0.88 | TSHR (0.60) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6194511-B1 | COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2001-02-27 | — | — | US | claimed |
| JP-1128966-A | — | — | None | — | — | JP | disclosed |
| WO-2024147426-A1 | CURABLE COMPOSITION, CURED FILM PRODUCED USING COMPOSITION, COLOR FILTER INCLUDING CURED FILM AND DISPLAY DEVICE INCLUDING COLOR FILTER | 삼성에스디아이 주식회사 | 2024-07-11 | — | — | WO | disclosed |
| US-20220411654-A1 | Radiation Curable Inkjet Ink for Manufacturing Printed Circuit Boards | AGFA-GEVAERT NV (BE) | 2022-12-29 | — | — | US | disclosed |
| US-20210002500-A1 | INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT NV (BE) | 2021-01-07 | — | — | US | disclosed |
| EP-0940694-B1 | Photochromic curable composition | TOKUYAMA CORP (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-6369269-B2 | Thiol and sulfur-containing O-(meth)acrylate compounds and use thereof | MITSUI CHEMICALS, INC. (JP) | 2002-04-09 | — | — | US | disclosed |
| US-6265510-B1 | OPTICS; LENSES | MITSUI CHEMICALS, INC. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-6194511-B1 | COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2001-02-27 | — | — | US | disclosed |
| US-6114485-A | STARTING MATERIAL FOR A RESIN COMPOSITION USED IN OPTICAL APPLICATIONS SUCH AS A LENS | MITSUI CHEMICALS, INC. (JP) | 2000-09-05 | — | — | US | disclosed |
| EP-0940694-A1 | Photochromic curable composition | TOKUYAMA CORPORATION (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5916987-A | OPTICAL RESIN; LENSES | MITSUI CHEMICALS, INC. (JP) | 1999-06-29 | — | — | US | disclosed |
| US-4939218-A | Sulfur-containing aliphatic acrylic compound, crosslinked polymer article, and lens | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1990-07-03 | — | — | US | disclosed |
| JP-H01128966-A | SULFUR-CONTAINING ALIPHATIC ACRYLIC COMPOUND | MITSUBISHI GAS CHEM CO INC | 1989-05-22 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002500-A1 | INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | ITGB3, RCOR3, RBCK1 | TSHR 3898/4885ALDH1A1 1196/4885TP53 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.